Congenital Syphilis: Responding to a National Epidemic?
This video features Christopher Golden, a neonatologist at Johns Hopkins Children’s Center, discussing the alarming rise in congenital syphilis and its implications for pediatric care.
Health Professionals
Back to Results
Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
Know Your Rights: Patient Coverage of PrEP with No Cost-Sharing What You Need to Know About New Federal Guidelines
This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.
Covering Costs of HIV PrEP: E-Learning Module Tips and Resources for Covering Costs of HIV PrEP
This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis).
Backsplicing of the HIV-1 Transcript Generates Multiple CircRNAs to Promote Viral Replication
This journal examines the role of circular RNAs (circRNAs) in HIV-1 replication, highlighting the discovery that backsplicing of the HIV-1 transcript produces multiple circRNAs that enhance viral replication.
A Handheld HIV Detection Platform Using Paper-Based Sample Preparation and Real-Time Isothermal Amplification
This journal discusses the development of a handheld platform designed for the detection of HIV, utilizing paper-based sample preparation and real-time isothermal amplification.
Outcomes of a Pilot Randomized Clinical Trial Testing Brief Interventions to Increase HIV Pre-Exposure Prophylaxis Uptake Among Rural People Who Inject Drugs Attending Syringe Services Programs
This journal presents findings from a pilot randomized clinical trial evaluating two brief interventions aimed at increasing HIV pre-exposure prophylaxis (PrEP) uptake among rural people who inject drugs (PWID) attending syringe services programs (SSPs) in Kentucky.
TB Treatment Regimen Cheat Sheet
This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB.
Provisional 2024 Tuberculosis Data, United States
This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.
NIAID Strategic Plan for Tuberculosis Research 2024 Update
This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB.